Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Poor Graft Function”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Testing effectiveness (Phase 2)Ended earlyNCT03948529
What this trial is testing

RevErsing Poor GrAft Function With eLtrombopag After allogeneIc Hematopoietic Cell trAnsplantation

Who this might be right for
LeukemiaGraft Failure
University Hospital, Lille 9
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06607367
What this trial is testing

REscuing Bone Marrow Function in Patients with AplaStic AnaEmia and Bone Marrow FaiLure Post AllogEneiC Transplantation 2

Who this might be right for
Poor Graft FunctionAplastic Anemia Idiopathic
Melbourne Health 20
Testing effectiveness (Phase 2)Ended earlyNCT02350777
What this trial is testing

T-cell Depleted Hematopoietic Stem Cell Boosts Without Conditioning for Poor Marrow Graft Function Following Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Hematopoietic Stem Cell TransplantPoor Marrow Graft Function
Memorial Sloan Kettering Cancer Center 4
Not applicableStudy completedNCT01857336
What this trial is testing

G-CSF Moblized Peripheral Harvest for Poor Engraftment After Stem Cell Transplantation

Who this might be right for
Poor Graft FunctionStem Cell TransplantationGraft Versus Host Disease
Peking University People's Hospital 20
Testing effectiveness (Phase 2)UnknownNCT02083718
What this trial is testing

Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionHematological Diseases
Nanfang Hospital, Southern Medical University 120
Not applicableLooking for participantsNCT06569082
What this trial is testing

CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure

Who this might be right for
Graft FailurePoor Graft Function
NYU Langone Health 21
Large-scale testing (Phase 3)Ended earlyNCT01564095
What this trial is testing

TOP-Study (Tacrolimus Organ Perfusion): Treatment of Ischemia Reperfusion Injury in Marginal Organs With an ex Vivo Tacrolimus Perfusion

Who this might be right for
Terminal Liver DiseaseIschemia Reperfusion InjuryGraft Dysfunction+2 more
Ludwig-Maximilians - University of Munich 25
Not applicableStudy completedNCT07200583
What this trial is testing

Protein A Immunoadsorption in Highly Sensitized Haplo-HSCT Patients

Who this might be right for
Hematologic MalignanciesHematologic DisordersAllogeneic Hematopoietic Stem Cell Transplantation (HSCT)+1 more
Ting YANG 50
Testing effectiveness (Phase 2)UnknownNCT00603330
What this trial is testing

Mesenchymal Stem Cell Infusion as Treatment for Steroid-Resistant Acute Graft Versus Host Disease (GVHD) or Poor Graft Function

Who this might be right for
Graft-versus-host DiseasePoor Graft FunctionLow Donor T-cell Chimerism
University of Liege 100
Testing effectiveness (Phase 2)Study completedNCT03236220
What this trial is testing

Effect of NAC on the Hematopoietic Reconstitution After Haploidentical Hematopoietic Stem Cell Transplantation

Who this might be right for
Haploidentical Hematopoietic Stem Cell Transplantation
Peking University People's Hospital 35
Testing effectiveness (Phase 2)Ended earlyNCT03718533
What this trial is testing

Study of Efficacy and Safety of Eltrombopag in Patients With Poor Graft Function

Who this might be right for
Poor Graft Function
Novartis Pharmaceuticals 10
Large-scale testing (Phase 3)Not Yet RecruitingNCT05669079
What this trial is testing

Decitabine and Umbilical Cord Blood for Poor Graft Function Post Allo-HSCT

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 100
Not applicableLooking for participantsNCT02438904
What this trial is testing

Compassionate Access of the Miltenyi Device for CD34+ Cell Selection

Who this might be right for
Blood And Marrow Transplantation
M.D. Anderson Cancer Center 200
Post-approval studies (Phase 4)Not Yet RecruitingNCT06171906
What this trial is testing

Mesenchymal Stem Cells for Treatment of Poor Graft Function After Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
MSC
ShiCang Yu 68
Testing effectiveness (Phase 2)UnknownNCT00876902
What this trial is testing

YSPSL for Prevention of Ischemic Reperfusion Injury in Patients Undergoing Cadaveric Orthotopic Liver Transplantation

Who this might be right for
Ischemia Reperfusion Injury
Y's Therapeutics, Inc. 36
Testing effectiveness (Phase 2)UnknownNCT02563366
What this trial is testing

Effect of BM-MSCs on Early Graft Function Recovery After DCD Kidney Transplant.

Who this might be right for
Kidney TransplantationAcute Kidney Tubular Necrosis
First Affiliated Hospital, Sun Yat-Sen University 120
Large-scale testing (Phase 3)UnknownNCT02240992
What this trial is testing

MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment

Who this might be right for
Stem Cell Transplantation, HematopoieticPoor Graft FunctionDelayed Platelet Engraftment+1 more
Nanfang Hospital, Southern Medical University 120
Large-scale testing (Phase 3)Study completedNCT02184819
What this trial is testing

Preoperative Levosimendan in CABG Patients With Poor LV Function

Who this might be right for
Coronary Artery Bypass GraftingLeft Ventricular Dysfonction
Assistance Publique - Hôpitaux de Paris 335
Early research (Phase 1)Looking for participantsNCT06792682
What this trial is testing

The Safety and Efficacy of Umbilical Cord Blood Mononuclear Cells in Patients With Secondary Poor Graft Function After Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
Institute of Hematology & Blood Diseases Hospital, China 15
Testing effectiveness (Phase 2)UnknownNCT03437603
What this trial is testing

Eltrombopag For Secondary Poor Graft Function Post Allogeneic Hematopoietic Stem Cell Transplantation

Who this might be right for
Poor Graft Function
The First Affiliated Hospital of Soochow University 20
Load More Results